Key Facts

Korsakoff syndrome (KS) is a chronic amnestic disorder most commonly seen as a sequel to Wernicke encephalopathy (together termed Wernicke-Korsakoff syndrome). The condition is characterised by a disproportionate memory impairment relative to other cognitive functions. It represents one of the most devastating consequences of chronic alcohol misuse.

Epidemiology

• Prevalence: approximately 1-2% of the general population at post-mortem; higher in chronic alcohol misusers
• Male:female ratio approximately 1.7:1 (reflecting alcohol misuse patterns)
• Mean age at presentation: 50-60 years
• Under-diagnosed in life: many cases only confirmed at post-mortem
• Non-alcoholic Korsakoff is rare but recognised (post-surgical, anorexia, hyperemesis)

Aetiology

• Progression from acute Wernicke encephalopathy (untreated or inadequately treated)
• Thiamine deficiency → irreversible damage to diencephalic structures
• Risk factors: chronic alcohol misuse, malnutrition, repeated episodes of Wernicke, genetic vulnerability (transketolase variant), concurrent liver disease

Pathophysiology

• Bilateral mammillary body neuronal loss and gliosis (most consistent finding)
• Medial thalamic nuclei damage: anterior nucleus and dorsomedial nucleus — disrupts the Papez circuit (hippocampus → mammillary bodies → anterior thalamus → cingulate cortex)
• Disruption of Papez circuit → inability to consolidate new episodic memories
• Relative sparing of cortical structures → preservation of intellectual function, attention, and procedural memory
• Frontal lobe dysfunction often co-exists: contributes to apathy, poor insight, and confabulation

Core Features

• Anterograde amnesia: profound inability to learn new information; most prominent deficit
• Retrograde amnesia: loss of previously formed memories, typically showing temporal gradient (remote memories better preserved than recent)
• Confabulation: spontaneous (unprovoked) or provoked — fabrication of experiences to fill memory gaps; more common early in the disease course
• Lack of insight (anosognosia): patient often unaware of memory deficits
• Preserved consciousness: alert and orientated (in contrast to the confusion of acute Wernicke)

Associated Features

• Apathy: lack of motivation and spontaneity (frontal lobe involvement)
• Emotional blunting: flattened affect
• Preserved procedural memory: can learn motor tasks and routines
• Preserved intellectual function: IQ often relatively spared
• Residual signs from Wernicke: nystagmus (60%), gait ataxia (60%), peripheral neuropathy

Red Flags

• Rapid cognitive decline — may suggest ongoing thiamine deficiency or alternative diagnosis
• New onset confusion in known Korsakoff — consider intercurrent illness, medication, further Wernicke episode
• Self-neglect and inability to maintain activities of daily living
• Capacity concerns: most patients lack capacity for complex decisions about care and finances

Bedside

• Cognitive screening: AMT (Abbreviated Mental Test), MoCA (Montreal Cognitive Assessment)
• Neuropsychological assessment: detailed memory testing showing disproportionate amnestic deficit
  • Severely impaired anterograde verbal and visual memory
  • Relative preservation of immediate recall and working memory
  • Executive dysfunction on frontal tests (Wisconsin Card Sort, verbal fluency)
• Capacity assessment: under Mental Capacity Act 2005 — assess for specific decisions

Bloods

• Red cell transketolase: may be low (confirms prior thiamine deficiency) but often normalises with treatment
• Serum thiamine: often normal by time Korsakoff presents (as acute Wernicke has resolved)
• FBC, LFTs, U&Es: assess ongoing alcohol-related damage
• B12 and folate: exclude concurrent deficiencies
• TFTs: exclude hypothyroidism as contributing factor
• Syphilis serology: in differential of young-onset dementia

Imaging

• MRI brain: mammillary body atrophy (most specific), third ventricular dilatation, medial thalamic changes, cerebellar vermis atrophy
• CT head: may show generalised atrophy; less sensitive than MRI for specific Korsakoff lesions

Special Tests

• Formal neuropsychological battery: confirms disproportionate amnestic pattern
• PET/SPECT: may show diencephalic and frontal hypometabolism (research tool)

Non-pharmacological

• Cognitive rehabilitation: errorless learning techniques, external memory aids (diaries, calendars, labels, routines)
• Structured environment: consistent daily routine reduces confusion and supports residual function
• Occupational therapy: functional assessment and adaptive strategies for activities of daily living
• Alcohol abstinence: essential to prevent further damage; supported by addiction services
• Nutritional support: balanced diet with continued supplementation

Pharmacological

• Thiamine replacement (long-term): oral thiamine 100 mg TDS indefinitely — prevents further deficiency but does not reverse established damage
• Multivitamin supplementation: including B-complex vitamins and folate
• No specific pharmacological treatment has proven effective for the amnestic syndrome
• Memantine and acetylcholinesterase inhibitors: limited evidence; occasionally trialled but no robust efficacy data
• Treat concurrent conditions: depression (common — SSRIs), anxiety, insomnia

Surgical

• Not applicable

Referral Criteria

• Neuropsychology: formal cognitive assessment for diagnosis confirmation and rehabilitation planning
• Alcohol services: ongoing relapse prevention support
• Social services: care needs assessment, potential for supported accommodation or residential care
• Court of Protection: if patient lacks capacity for financial and welfare decisions
• Community mental health team: if concurrent psychiatric co-morbidity

Outcomes

• ~25% show significant improvement over 12-24 months with abstinence and nutritional support
• ~50% show some improvement but remain significantly impaired
• ~25% show no improvement and require long-term institutional care
• Full recovery is rare — probably fewer than 5-10%
• Younger patients and those with shorter duration of alcohol misuse have better prognosis

Complications

• Permanent disability: inability to live independently
• Long-term care costs: significant burden on health and social care
• Depression: common in those with some insight into deficits
• Continued alcohol misuse: further brain injury if abstinence not maintained
• Physical co-morbidities: ongoing alcohol-related organ damage
• Safeguarding concerns: vulnerability to exploitation, self-neglect

Wernicke-Korsakoff Syndrome: Key Distinctions

Papez Circuit